Recap: Corbus Pharmaceuticals Q2 Earnings

 

Corbus Pharmaceuticals CRBP reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Corbus Pharmaceuticals missed estimated earnings by 16.67%, reporting an EPS of $-0.07 versus an estimate of $-0.06.

Revenue was down $136 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 8.18% drop in the share price the next day.

Here's a look at Corbus Pharmaceuticals's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.08 -0.11 -0.11 -0.12
EPS Actual -0.08 -0.08 -0.02 -0.15
Revenue Estimate 150K 350K 650K 870K
Revenue Actual 0 0 97K 136K

To track all earnings releases for Corbus Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!